{"transactions":[{"id":827690,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-27T00:01:00.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest as to 25% on March 24, 2027, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.86,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-035403","document":"tm269848-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926035403/tm269848-2_4seq1.xml","form_type":"4"}},{"id":1195078,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-22T00:00:04.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest as to 25% on March 20, 2026, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":2.29,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-25-011175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315225011175/ownership.xml","form_type":"4"}},{"id":1309009,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-08T02:00:08.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":271325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest as to 25% on January 6, 2026 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":271325,"derivative":{"exercise_price":2.44,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":271325},"source":{"system":"sec-edgar","filing":"0001493152-25-001281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315225001281/ownership.xml","form_type":"4"}},{"id":1436331,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Interim CEO"}}],"security":"Common Stock","published_at":"2024-08-12T21:23:31.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":14400,"price":1.01,"value":14544.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.98 to $1.07 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":14400,"source":{"system":"sec-edgar","filing":"0001493152-24-031378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224031378/ownership.xml","form_type":"4"}},{"id":1546142,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-04-08T23:44:54.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on April 8, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":3.56,"expiration_date":"2034-04-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-24-013983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224013983/ownership.xml","form_type":"4"}},{"id":3957906,"issuer":{"id":4313,"kind":"organization","name":"SELLAS Life Sciences Group, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-24T20:53:27.000Z","date":"2018-04-20","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-quarter (1/4) of the option shares will vest and became exercisable one year from the April 20, 2018 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.38,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-025967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1390478/000120919118025967/doc4.xml","form_type":"4"}}]}